Essential Criteria BioPharmaceutical Investors Seek When Evaluating Compounds and Companies  

  • 81% of projects in the global biopharmaceutical pipeline are owned by small-to mid-sized companies
  • Success often depends on outside investment in out-license, acquisition, or commercialization agreements
  • Fully integrated pharmaceutical companies, as well as venture capitalists, look for specific attributes when evaluating investment opportunities


Field will not be visible to web visitor

Copyright 2019 Industry Dive